Results 81 to 90 of about 36,119 (263)

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

International Journal of Nephrology, 2017
Denosumab increases bone mineral density (BMD) in patients not receiving hemodialysis therapy. However, limited data are available in the literature concerning the use of denosumab in hemodialysis patients.
Hiroya Takami, Kazunori Washio, Hiromichi Gotoh   +2 more
doaj   +1 more source

Denosumab in men receiving androgen-deprivation therapy for prostate cancer. [PDF]

, 2009
Androgen-deprivation therapy is well-established for treating prostate cancer but is associated with bone loss and an increased risk of fracture. We investigated the effects of denosumab, a fully human monoclonal antibody against receptor activator of ...
Denosumab, HALT Prostate Cancer Study Group, Egerdie, B, Feldman, R, Goessl, C, Heracek, J, Hernández Toriz, N, Ke, C, Kupic, A, Leder, BZ, Saad, F, Smith, MR, Szwedowski, M, Tammela, TL   +12 more
core   +1 more source

Review of: "Simplifying the dental/periodontal management of patients with metabolic bone fragility receiving treatment with denosumab" [PDF]

, 2021
Francesco Erovigni
openalex   +1 more source

Histopathology, Diagnosis, Management and Treatment Outcomes of Cemental Tears: A Retrospective Observational Cohort Study

International Endodontic Journal, EarlyView.
ABSTRACT Introduction Diagnosing cemental tears remains challenging, and treatment outcomes can be unpredictable; recommendations for their diagnosis and management are primarily based on case reports and anecdotal experience. Although a classification has been developed for cemental tears, its clinical applicability and importance have yet to be ...
Angeline Hui Cheng Lee, Mei Zhi Ting, May Chun Mei Wong, Chengfei Zhang   +3 more
wiley   +1 more source

Routine use of denosumab for prevention of skeletal-related events in patients with bone metastases from prostate carcinoma in Bulgaria: a prospective observational study

Biotechnology & Biotechnological Equipment
Bulgarian real-world data on denosumab use for the prevention of skeletal-related events (SREs) associated with bone metastases (BM) from prostate cancer (PC) are lacking.
Antoaneta Tomova, Valentina Ianakieva, Katja Bjorklof, Adrian Olszewski, Miglena Petrova   +4 more
doaj   +1 more source

Recommendations for bone‐directed therapy in patients with neuroendocrine tumour skeletal metastases at the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting

Internal Medicine Journal, EarlyView.
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley, Marianne S Elston, Ben Lawrence, Veronica Boyle   +3 more
wiley   +1 more source

Current perspectives on skeletal health and cancer progression across the disease continuum in breast cancer—The role of bisphosphonates [PDF]

, 2012
Pre-clinical and clinical evidence suggest that bisphosphonates inhibit both bone resorption and cancer progression. New and updated analyses from several large, controlled studies in pre- and post-menopausal women with early stage breast cancer (BC ...
Aft, R.
core   +2 more sources

Trend Analysis of Medically Related Osteonecrosis of the Jaw in the United States Using US National Inpatient Data From 2016 to 2022

Journal of Public Health Dentistry, EarlyView.
ABSTRACT Objectives This study presents a trend analysis of Medication‐Related Osteonecrosis of the Jaw (MRONJ) using US National Inpatient Sample (NIS) data from 2016 to 2022, providing insights into its epidemiology, comorbidities, and economics.
N. Sheshashayee, M. B. Rao, E. Holmes, D. G. Krishnan   +3 more
wiley   +1 more source

Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis

Drug, Healthcare and Patient Safety, 2011
E Michael LewieckiNew Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico, USAAbstract: Denosumab is a fully human monoclonal antibody to receptor activator of nuclear factor kappa-B ligand (RANKL), a cytokine member of the ...
Lewiecki EM
doaj  

Guillain-Barré Syndrome following Denosumab Administration in a Patient with Chronic Kidney Disease

Indian Journal of Kidney Diseases
Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyradiculoneuropathy most often triggered by infections, but drug-induced cases are increasingly recognized.
Saurabh Puri, Anand Naveen Thakur, Hari Shankar Meshram, Chandani Bhagat, Rajendra Prasad Mathur   +4 more
doaj   +1 more source